We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Nova Alternative RNA Splicing Targets Neuronal Proteins

By Biotechdaily staff writers
Posted on 26 Nov 2003
A new study describes a method to purify protein-RNA complexes from mouse brain that allows researchers to identify an array of RNA molecules regulated by Nova, an RNA-binding protein that regulates alternative RNA splicing.

Nova proteins are neuron-specific antigens targeted in paraneoplastic opsoclonus myoclonus ataxia (POMA), an autoimmune neurologic disease characterized by abnormal motor inhibition. More...
Nova proteins regulate neuronal pre-messenger RNA splicing by directly binding to RNA.

RNA splicing is an essential, precisely regulated post-transcriptional process that occurs prior to mRNA translation. A gene is first transcribed into a pre-messenger RNA (pre-mRNA), which is a copy of the genomic DNA containing intronic regions destined to be removed during pre-mRNA processing (RNA splicing), as well as exonic sequences that are retained within the mature mRNA. During RNA splicing, exons can either be retained in the mature message or targeted for removal in different combinations to create a diverse array of mRNAs from a single pre-mRNA, a process referred to as alternative RNA splicing.

Alternative splice events that affect the protein coding region of the mRNA will give rise to proteins that differ in their sequence and therefore in their activities. Alternative splicing within the noncoding regions of the RNA can result in changes in regulatory elements such as translation enhancers or RNA stability domains, which may have a dramatic effect on the level of protein expression.

Investigators at Rockefeller University (New York, NY, USA; www.rockefeller.edu) employed a technique called cross-linking and immunoprecipitation (CLIP) to chemically bond the NOVA protein to its RNA targets. In a novel adaptation of this method, they applied it to intact mouse brains in order to trap the protein-RNA complexes as they are in situ. In the November 14, 2003, issue of Science, they reported that 34 transcripts were identified multiple times by Nova CLIP. Three-quarters of these encoded proteins functioned at the neuronal synapse, and one-third were involved in neuronal inhibition.

"Looking at these targets as a group, they have a tremendous biological coherence to them,” observed senior author Dr. Robert B. Darnell, a Howard Hughes Medical Institute investigator at Rockefeller University. "Almost 70% of them are RNAs that have something to do with the neuronal synapse. One-third of the Nova synaptic RNA targets encode proteins involved in inhibiting neuronal function. Regulating neuronal inhibition plays a key role in the balance-controlling nervous system function normally as well as in neurological disorders such as epilepsy.”



Related Links:
Rockefeller University

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
H-FABP Assay
Heart-Type Fatty Acid-Binding Protein Assay
Immunofluorescence Analyzer
IFA System
New
Portable POCT Blood Gas Analyzer
BD100
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Alzheimer’s pathology can start 15 to 20 years before symptoms, and validated tools that reach patients earlier help pave the way for earlier detection. (Image Credit: Adobe Stock)

Alzheimer’s Blood Test Becomes First FDA-Cleared Option for Adults as Young as 40

C2N Diagnostics’ PrecivityAD2 blood test was cleared by the U.S. Food and Drug Administration (FDA) on August 20, 2026, for adults as young as 40 who are experiencing signs of cognitive impairment, according... Read more

Pathology

view channel
Image: Adrenal gland tumor stained with hematoxylin and eosin (top) and CYP11B2 (bottom) (Photo courtesy of Christofer Juhlin)

Simple Immunohistochemical Size Ratio Improves Classification of Primary Aldosteronism

Primary aldosteronism is a common but underdiagnosed cause of hypertension, in which excess aldosterone promotes salt retention and raises blood pressure. Identifying the dominant source of hormone overproduction... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.